| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/26/2006 | CA2574060A1 Immune modulating compounds from fungi |
| 01/26/2006 | CA2573164A1 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 01/26/2006 | CA2571250A1 Galnts as modifiers of the igfr pathway and methods of use |
| 01/26/2006 | CA2570602A1 Agents for regulating the activity of interferon-producing cells |
| 01/26/2006 | CA2568952A1 Novel antigen-binding polypeptides and their uses |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619247A1 High throughput synthesis system and synthesizer for automatically performing the system |
| 01/25/2006 | EP1619208A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein |
| 01/25/2006 | EP1619202A2 immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/25/2006 | EP1618891A1 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor |
| 01/25/2006 | EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles |
| 01/25/2006 | EP1618183A2 Novel bacillus 029cel cellulase |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618177A2 Production of high mannose proteins in plant culture |
| 01/25/2006 | EP1617860A2 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 01/25/2006 | EP1617802A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 01/25/2006 | EP1204738B1 A method for decreasing the foam formation during cultivation of a microorganism |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP1071798B1 Constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | CN1726285A Methods and compositions for immunization against HIV |
| 01/25/2006 | CN1726284A Protein modification |
| 01/25/2006 | CN1726283A Production of multimeric fusion proteins using a C4BP scaffold |
| 01/25/2006 | CN1724684A Preparation method of oligopeptide with eliminating free radical activity |
| 01/25/2006 | CN1724683A Method of preparing peptide having trypsin inhibition activity by using complex enzyme enzymolysis oyster |
| 01/25/2006 | CN1724682A Cordyceps polypeptide product and its preparation method and application |
| 01/25/2006 | CN1724674A Expression method of insect defensin in pichia |
| 01/25/2006 | CN1724673A Expression method of America poke root antivirus protein (PAR) in pasteur pichia |
| 01/25/2006 | CN1724672A Constitution type expression carrier and its application |
| 01/25/2006 | CN1724665A Human new gene TRIKS and its coded protein |
| 01/25/2006 | CN1724663A Method of preparing natural human thymosin a1 using series expression mode |
| 01/25/2006 | CN1238516C Production of polysaccharide protein by deep fermentation of hysteriales for anticancer |
| 01/25/2006 | CN1238512C Method for preparing connective tissue growth factor C-zone antigen |
| 01/25/2006 | CN1238508C Distillersyeast recombined hepatitis B virus surface antigen stream addition femrentation process |
| 01/25/2006 | CN1238500C Immunology epitope of hog cholera virus feature and application thereof |
| 01/25/2006 | CN1238499C Antibody against AIDS virus O and its production cell series and uses |
| 01/25/2006 | CN1238498C Method for parameter control of the process for culturing serum-suspension free animal cell |
| 01/25/2006 | CN1238381C Anti-cancer surface antigen of p185 mono-antigen mosaic antibody and its preparation |
| 01/25/2006 | CN1238379C New osteoclast formation inhibiting factor and its coding sequence and use |
| 01/25/2006 | CN1238376C Mutatant protein of human stem cell growth factor as well as its preparing method and medicine composition |
| 01/25/2006 | CN1238375C Chlorine-ion/ bicarbonate radical exchange protein drived by sodium-ion |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/24/2006 | US6989441 Nucleotide sequences coding transport protein for use in the treatment of vision defcets, liver, cardiovascular, nervous system and cell proliferation disorders |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989265 Bacteria with reduced genome |
| 01/24/2006 | US6989262 Plasmin variants and uses thereof |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |
| 01/24/2006 | US6989251 Batch fermentation of polypeptides; cosmetics; foods; medicines |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989145 Chimeric antibody for use in the diagnosis and treatment of blood cancer and immune defects |
| 01/24/2006 | US6989144 Glycoprotein VI antibodies and uses thereof |
| 01/24/2006 | CA2351315C Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 01/24/2006 | CA2110019C Immunoassays for determining vitamin b12, and reagents and kits therefor |
| 01/23/2006 | WO2007015691A2 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/23/2006 | CA2576464A1 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/19/2006 | WO2006007023A2 The ubeg2 binding domain in the ubiquitin ligase gp78 and methods of use thereof |
| 01/19/2006 | WO2006006695A1 Mouse monoclonal antibody recognizing acetyllysine, labeled antibody and utilization of the same |
| 01/19/2006 | WO2006006693A1 Anti-glypican 3 antibody |
| 01/19/2006 | WO2006005757A2 Blood pressure lowering oligopeptides |
| 01/19/2006 | WO2005113775B1 Pproduction of a protein localized to the endoplasmic reticulum protein bodies in a transgenic plant and seed |
| 01/19/2006 | WO2005089285A3 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 01/19/2006 | WO2005056576A3 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/19/2006 | WO2005017149A8 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 01/19/2006 | US20060015969 Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/19/2006 | US20060015958 Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 01/19/2006 | US20060015955 Alpha(1,3)Galactosyltransferase enzyme that assembles the Galalpha(1,3)Gal xenoantigen |
| 01/19/2006 | US20060014942 Nucleotide sequences for the control of the expression of DNA sequences in a cell host |
| 01/19/2006 | US20060014941 Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same |
| 01/19/2006 | US20060014940 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014931 Novel promoter |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014691 Mechanically activated channel blocker |
| 01/19/2006 | US20060014688 Methods of inhibiting tumor cell proliferation |
| 01/19/2006 | US20060014687 Bone delivery conjugates and method of using same to target proteins to bone |
| 01/19/2006 | US20060014683 Procoagulant protein comprising polypeptide with amino acid substitutions; resistant to activated protein C; von Willebrand factor binding site deleted and thrombin cleavage site is mutated; treating hemophilia |
| 01/19/2006 | US20060014672 Tumor specific oligosaccharide epitopes and use thereof |
| 01/19/2006 | US20060014668 Antigenic gp 100 compounds for therapy and diagnosis and methods of using same |
| 01/19/2006 | US20060014265 Mutant alpha-amylases |
| 01/19/2006 | US20060014262 Beta1,3-galactosyltransferase and DNA encoding the same |
| 01/19/2006 | US20060014255 Methods for lyophilizing competent cells |
| 01/19/2006 | US20060014254 Albumin fusion proteins |
| 01/19/2006 | US20060014252 Flk-1 binding protein |
| 01/19/2006 | US20060014251 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-II subunit (CACNA1I) |
| 01/19/2006 | US20060014250 Descendants of bacteria devoid of N terminal formylation useful for the production of proteins and peptides |
| 01/19/2006 | US20060014249 Human G-protein coupled receptor |
| 01/19/2006 | US20060014248 Tumor Necrosis Factor Super Family (TNFSF) with antagonist activity ; for autoimmune conditions |
| 01/19/2006 | US20060014247 DNA constructs for obtaining in a filamentous fungus host (actinomycete) a higher production level of a carbohydrate degrading (CD) enzyme, having in its original state a catalytic module (CAT) and a carbohydrate binding module (CBM) separated by a linker region; Xylanase; use in paper industry |
| 01/19/2006 | US20060014246 Canine cold- and menthol-sensitive receptor 1 |
| 01/19/2006 | US20060014245 Immunotoxins containing a cytotoxic RNAse fused to the N-terminus of one antibody variable domain prepared and retain the ability to specifically bind antigen; cancer |
| 01/19/2006 | US20060014244 Novel nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and ATPase-like molecules and uses therefor |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014241 Extended glucagon-like peptide-1 analogs |
| 01/19/2006 | US20060014240 Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug |
| 01/19/2006 | US20060014239 Method and device for the biotechnological production of valuable products |
| 01/19/2006 | US20060014226 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014217 Sphingomyelin detecting probe |